Barclays Maintains an 'Overweight' on Halozyme Therapeutics (HALO); Underappreciated Assets Plus Possible Partnership On Deck

Go back to Barclays Maintains an 'Overweight' on Halozyme Therapeutics (HALO); Underappreciated Assets Plus Possible Partnership On Deck
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 74.55 -0.5 (0.67%)
Previous Close $75.05    52 Week High $18.39 
Open $74.54    52 Week Low $6.96 
Day High $74.63    P/E N/A 
Day Low $74.48    EPS $-0.58 
Volume 22,759       

Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1138.37 -14.17 (1.23%)
Previous Close $1152.54    52 Week High $88.16 
Open $1146.96    52 Week Low $67.88 
Day High $1150.05    P/E 263.51 
Day Low $1136.56    EPS $4.32 
Volume 132,583       

Medtronic Inc. (NYSE: MDT) Delayed: 80.10 +0.80 (1.01%)
Previous Close $79.30    52 Week High $89.27 
Open $79.61    52 Week Low $71.03 
Day High $80.50    P/E 22.76 
Day Low $79.50    EPS $3.52 
Volume 222,851       

NOVO-NORDISK A/S (NYSE: NVO) Delayed: 49.72 +0.65 (1.32%)
Previous Close $49.07    52 Week High $59.00 
Open $49.36    52 Week Low $32.80 
Day High $49.79    P/E N/A 
Day Low $49.36    EPS $0.00 
Volume 516,196       

SANOFI (NASDAQ: SNY) Delayed: 43.10 -0.08 (0.19%)
Previous Close $43.18    52 Week High $44.76 
Open $43.09    52 Week Low $36.81 
Day High $43.15    P/E N/A 
Day Low $43.04    EPS $0.00 
Volume 86,948